4.6 Article

Crystallographic structure of the tetratricopeptide repeat domain of Plasmodium falciparum FKBP35 and its molecular interaction with Hsp90 C-terminal pentapeptide

期刊

PROTEIN SCIENCE
卷 18, 期 10, 页码 2115-2124

出版社

WILEY
DOI: 10.1002/pro.226

关键词

Plasmodium falciparum; FKBP35; TPR domain; Hsp90; NMR titration; surface plasmon resonance; molecular docking; MEEVD peptide

资金

  1. Ministry of Education Singapore [T206B3217]

向作者/读者索取更多资源

Plasmodium falciparum FK506-binding protein 35 (PfFKBP35) that binds to FK506 contains a conserved tetratricopeptide repeat (TPR) domain. Several known TPR domains such as Hop, PPP5, CHIP, and FKBP52 are structurally conserved and are able to interact with molecular chaperones such as Hsp70/Hsp90. Here, we present the crystal structure of PfFKBP35-TPR and demonstrate its interaction with Hsp90 C-terminal pentapeptide (MEEVD) by surface plasmon resonance and nuclear magnetic resonance spectroscopy-based binding studies. Our sequence and structural analyses reveal that PfFKBP35 is similar to Hop and PPP5 in possessing all the conserved residues which are important for carboxylate clamping with Hsp90. Mutational studies were carried out on positively charged clamp residues that are crucial for binding to carboxylate groups of aspartate, showing that all the mutated residues are important for Hsp90 binding. Molecular docking and electrostatic calculations demonstrated that the MEEVD peptide of Hsp90 can form aspartate clamp unlike FKBP52. Our results provide insightful information and structural basis about the molecular interaction between PfFKBP35-TPR and Hsp90.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Mutational Analysis of Mycobacterial F-ATP Synthase Subunit δ Leads to a Potent δ Enzyme Inhibitor

Amaravadhi Harikishore, Wuan-Geok Saw, Priya Ragunathan, Dennis Litty, Thomas Dick, Volker Mueller, Gerhard Gruber

Summary: This study elucidated the differences in the amino acid composition and structural features of the mycobacterial F-ATP synthase compared to other counterparts, paving the way for discovering molecules that can interfere with the regulative mechanisms of this essential energy converter. The essentiality of the mycobacterial peripheral stalk subunit delta for effective catalysis was demonstrated, leading to the identification of a potent subunit delta inhibitor. Targeting the delta subunit shows potential for developing F-ATP synthase inhibitors.

ACS CHEMICAL BIOLOGY (2022)

Article Cardiac & Cardiovascular Systems

Inhibition of IL11 Signaling Reduces Aortic Pathology in Murine Marfan Syndrome

Wei-Wen Lim, Jinrui Dong, Benjamin Ng, Anissa A. Widjaja, Chen Xie, Liping Su, Xiu-Yi Kwek, Nicole G. Z. Tee, Chee Jian Pua, Sebastian Schafer, Sivakumar Viswanathan, Stuart A. Cook

Summary: IL11 is upregulated in the aorta of Marfan syndrome patients, leading to aortic dilatation, inflammation, and fibrosis. Therapeutic inhibition of IL11 may be a new approach in treating Marfan syndrome.

CIRCULATION RESEARCH (2022)

Article Urology & Nephrology

A Neutralizing IL-11 Antibody Improves Renal Function and Increases Lifespan in a Mouse Model of Alport Syndrome

Anissa A. Widjaja, Shamini G. Shekeran, Eleonora Adami, Joyce G. Wei Ting, Jessie Tan, Sivakumar Viswanathan, Sze Yun Lim, Puay Hoon Tan, Norbert Huebner, Thomas Coffman, Stuart A. Cook

Summary: This study demonstrates that neutralizing IL-11 antibody can reduce fibrosis, inflammation, and epithelial-to-mesenchymal transition while improving renal function in an Alport syndrome mouse model. Combined with ACE inhibition, anti-IL-11 therapy can synergistically extend lifespan. These findings suggest that targeting IL-11 holds promise for treating progressive kidney disease in Alport syndrome.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)

Article Biochemistry & Molecular Biology

Atomic solution structure of Mycobacterium abscessus F-ATP synthase subunit ε and identification of Ep1MabF1 as a targeted inhibitor

Joon Shin, Amaravadhi Harikishore, Chui Fann Wong, Priya Ragunathan, Thomas Dick, Gerhard Gruber

Summary: Mycobacterium abscessus (Mab) is a clinically relevant nontuberculous mycobacterium that is intrinsically multi-drug-resistant, causing difficult-to-cure lung disease. Structural and dynamic studies of the Mab epsilon subunit reveal insights into the coupling process within the protein, highlighting the potential for development of novel antimycobacterial compounds. Evaluation of the inhibitor Ep1MabF1 demonstrates its effectiveness in inhibiting Mab growth and bacterial ATP synthesis.

FEBS JOURNAL (2022)

Article Biochemistry & Molecular Biology

IL11 Stimulates IL33 Expression and Proinflammatory Fibroblast Activation across Tissues

Anissa A. Widjaja, Sonia Chothani, Sivakumar Viswanathan, Joyce Wei Ting Goh, Wei-Wen Lim, Stuart A. Cook

Summary: IL11 is pro-inflammatory in fibroblasts by activating the signaling pathways and promoting transcriptional responses related to inflammation, leading to the upregulation of various inflammatory factors.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

Hepatocyte Specific gp130 Signalling Underlies APAP Induced Liver Injury

Jinrui Dong, Wei-Wen Lim, Shamini G. Shekeran, Jessie Tan, Sze Yun Lim, Joyce Wei Ting Goh, Benjamin L. George, Sebastian Schafer, Stuart A. Cook, Anissa A. Widjaja

Summary: This study investigated the role of IL11 and gp130 in APAP-induced liver injury using mouse models with conditional knockout of Il11 or gp130 in hepatocytes. The results showed that IL11/gp130 signaling contributes to liver damage and inhibits regeneration in APAP toxicity.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Chemistry, Medicinal

Structural and Mechanistic Insights into Mycobacterium abscessus Aspartate Decarboxylase PanD and a Pyrazinoic Acid-Derived Inhibitor

Wuan-Geok Saw, Chen Yen Leow, Amaravadhi Harikishore, Joon Shin, Malcolm S. Cole, Wassihun Wedajo Aragaw, Priya Ragunathan, Pooja Hegde, Courtney C. Aldrich, Thomas Dick, Gerhard Grueber

Summary: This study investigated the structure-function relationship of PanD in Mycobacterium abscessus (Mab), a non-tuberculous mycobacterial lung pathogen, and compared it to Mycobacterium tuberculosis (Mtb) PanD. The solution structure of Mab PanD was determined using solution X-ray scattering data, revealing the orientation of the C-termini relative to the catalytic core. Enzymatic and mutational analyses identified critical residues involved in substrate tunnel and enzymatic activity. A potent inhibitor of Mab PanD was discovered using a library of POA analogues. Unlike PZA and POA, this inhibitor showed significant antibacterial activity against different subspecies of Mab.

ACS INFECTIOUS DISEASES (2022)

Article Biochemistry & Molecular Biology

Structure activity relationship of pyrazinoic acid analogs as potential antimycobacterial agents

Pooja V. Hegde, Wassihun W. Aragaw, Malcolm S. Cole, Gorakhnath Jachak, Priya Ragunathan, Sachin Sharma, Amaravadhi Harikishore, Gerhard Gruber, Thomas Dick, Courtney C. Aldrich

Summary: Tuberculosis (TB) is a major cause of infectious disease-related mortality and morbidity. Pyrazinamide (PZA) is a crucial component of TB treatment, but its mechanism of action is still unclear. Recent research has shown that the active metabolite pyrazinoic acid (POA) induces targeted protein degradation of the enzyme PanD in Mycobacterium tuberculosis (Mtb). By designing POA analogs, researchers have made progress in improving potency and overcoming PZA resistance.

BIOORGANIC & MEDICINAL CHEMISTRY (2022)

Article Multidisciplinary Sciences

Targeting endogenous kidney regeneration using anti-IL11 therapy in acute and chronic models of kidney disease

Anissa A. Widjaja, Sivakumar Viswanathan, Shamini G. Shekeran, Eleonora Adami, Wei-Wen Lim, Sonia Chothani, Jessie Tan, Joyce Wei Ting Goh, Hui Mei Chen, Sze Yun Lim, Carine M. Boustany-Kari, Julie Hawkins, Enrico Petretto, Norbert Huebner, Sebastian Schafer, Thomas M. Coffman, Stuart A. Cook

Summary: In severe kidney disease, inhibiting IL11 can restore kidney function and reverse tissue damage through promoting regeneration.

NATURE COMMUNICATIONS (2022)

Article Microbiology

Cryo-Electron Microscopy Structure of the Mycobacterium tuberculosis Cytochrome bcc:aa3 Supercomplex and a Novel Inhibitor Targeting Subunit Cytochrome cI

Vikneswaran Mathiyazakan, Chui-Fann Wong, Amaravadhi Harikishore, Kevin Pethe, Gerhard Gruber

Summary: The Mycobacterial cytochrome bcc:aa(3) complex is a supercomplex that combines three cytochrome oxidases into one machine, which performs electron transfer and proton transport for ATP synthesis. It is a valid drug target for Mycobacterium tuberculosis infections.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2023)

Review Pharmacology & Pharmacy

Novel targets and inhibitors of the Mycobacterium tuberculosis cytochrome bd oxidase to foster anti-tuberculosis drug discovery

Amaravadhi Harikishore, Vikneswaran Mathiyazakan, Kevin Pethe, Gerhard Gruber

Summary: This review discusses the structure and mechanism of Mtb's respiratory chain complex, cytochrome bd oxidase, as well as its features in structure-activity relationship. It emphasizes the importance of a deeper understanding of the structure and mechanism of Mtb's cytochrome bd oxidase for drug development.

EXPERT OPINION ON DRUG DISCOVERY (2023)

Editorial Material Pathology

The Pathobiology of IL-11 in Kidney Disease From Epithelial Cell to Fibroblast and Back Again

Anissa A. Widjaja, Stuart A. Cook

AMERICAN JOURNAL OF PATHOLOGY (2023)

Article Chemistry, Multidisciplinary

Coomassie brilliant blue G-250 acts as a potential chemical chaperone to stabilize therapeutic insulin

Ranit Pariary, Sandip Dolui, Gourav Shome, Sk Abdul Mohid, Achintya Saha, Bhisma N. Ratha, Amaravadhi Harikishore, Kuladip Jana, Atin K. Mandal, Anirban Bhunia, Nakul C. Maiti

Summary: Our studies demonstrate that Coomassie Brilliant Blue G-250 shows promise as a chemical chaperone for stabilising the alpha-helical native human insulin conformers, preventing their aggregation and increasing insulin secretion. This multipolar effect, along with its non-toxic nature, could be valuable for the development of highly bioactive, targeted, and biostable therapeutic insulin.

CHEMICAL COMMUNICATIONS (2023)

Article Biochemistry & Molecular Biology

Cardiomyocyte-Restricted Expression of IL11 Causes Cardiac Fibrosis, Inflammation, and Dysfunction

Mark Sweeney, Katie O'Fee, Chelsie Villanueva-Hayes, Ekhlas Rahman, Michael Lee, Konstantinos Vanezis, Ivan Andrew, Wei-Wen Lim, Anissa Widjaja, Paul J. R. Barton, Stuart A. Cook

Summary: This study demonstrates that IL11 expression in cardiomyocytes can lead to severe cardiac fibrosis and inflammation, as well as endothelial-to-mesenchymal transition and left ventricular dysfunction.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Chemistry, Medicinal

Structural and Mechanistic Insights into Mycobacterium abscessus Aspartate Decarboxylase PanD and a Pyrazinoic Acid-Derived Inhibitor

Wuan-Geok Saw, Chen Yen Leow, Amaravadhi Harikishore, Joon Shin, Malcolm S. Cole, Wassihun Wedajo Aragaw, Priya Ragunathan, Pooja Hegde, Courtney C. Aldrich, Thomas Dick, Gerhard Gruber

Summary: This study conducted the first structure-function studies on PanD encoded by the nontuberculous mycobacterial lung pathogen Mycobacterium abscessus (Mab), revealing the differences and similarities of Mab and Mtb PanD. Additionally, a library of recombinant Mab PanD mutants based on structural information and PZA/POA resistant PanD mutations in Mtb identified a potent inhibitor of Mab PanD. The inhibitor showed electrostatic- and hydrogen bonding interaction with the target enzyme and exhibited antibacterial activity against the three subspecies of Mab.

ACS INFECTIOUS DISEASES (2022)

暂无数据